beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->3)-beta-D-GlcpNAc-(1->3)--D-GalpNAc

Term ID

CHEBI:149033

Synonyms

2-acetamido-2-deoxy-beta-D-gluco-hexopyranosyl-(1->3)-beta-D-galacto-hexopyranosyl-(1->3)-2-acetamido-2-deoxy-beta-D-gluco-hexopyranosyl-(1->3)-2-acetamido-2-deoxy-D-galacto-hexopyranose
2-acetamido-2-deoxy-beta-D-glucopyranosyl-(1->3)-beta-D-galactopyranosyl-(1->3)-2-acetamido-2-deoxy-beta-D-glucopyranosyl-(1->3)-2-acetamido-2-deoxy-D-galactopyranose
GlcNAc(b1-3)Gal(b1-3)GlcNAc(b1-3)GalNAc
N-[(2S,3R,4R,5S,6R)-2-[(2R,3R,4S,5S,6R)-2-[(2R,3R,4R,5S,6R)-3-acetamido-2-[(3R,4R,5R,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-4,5-dihydroxy-6-(hydrox

Definition

An aminotetrasaccharide consisting of 2-acetamido-β-D-glucopyranose, β-D-galactopyranose, 2-acetamido-β-D-glucopyranose and 2-acetamido-D-galactopyranose residues joined in sequence by (1→3) glycosidic linkages.

References

glygen:G30697FM
glytoucan:G30697FM

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->3)-beta-D-GlcpNAc-(1->3)--D-GalpNAc

Phenotype where environments contain beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->3)-beta-D-GlcpNAc-(1->3)--D-GalpNAc

Phenotype modified by environments containing beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->3)-beta-D-GlcpNAc-(1->3)--D-GalpNAc

Phenotype affecting beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->3)-beta-D-GlcpNAc-(1->3)--D-GalpNAc

Human Disease Model